Search research articles
Contact Us
Filters
Showing results (141-150 of 169) with videos related to
Page
of 17
Sort By:
Journal of Molecular Medicine (Berlin, Germany)
|
December 17, 2023
Correction to: Periostin secreted by cancer‑associated fibroblasts promotes cancer progression and drug resistance in non‑small cell lung cancer
Fumiaki Takatsu, Ken Suzawa, Shuta Tomida, et al.
Scientific Reports
|
December 24, 2016
Interaction of cytokeratin 19 head domain and HER2 in the cytoplasm leads to activation of HER2-Erk pathway
Tomoaki Ohtsuka, Masakiyo Sakaguchi, Hiromasa Yamamoto, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
October 13, 2023
Periostin secreted by cancer-associated fibroblasts promotes cancer progression and drug resistance in non-small cell lung cancer
Fumiaki Takatsu, Ken Suzawa, Shuta Tomida, et al.
Cancer Immunology Research
|
July 1, 2025
Close Spatial Interactions between Cancer Cells and Cancer-Associated Fibroblasts Suppress Antitumor Immunity
Yuto Naoi, Yumi Inukai, Tomoka Izumikawa, et al.
Oncology Research
|
September 20, 2017
β-1,3-Galactosyl-<i>O</i>-Glycosyl-Glycoprotein β-1,6-<i>N</i>-Acetylglucosaminyltransferase 3 Increases MCAM Stability, Which Enhances S100A8/A9-Mediated Cancer Motility
I Wayan Sumardika, Chen Youyi, Eisaku Kondo, et al.
JAMA Oncology
|
October 15, 2020
Site-Specific and Targeted Therapy Based on Molecular Profiling by Next-Generation Sequencing for Cancer of Unknown Primary Site: A Nonrandomized Phase 2 Clinical Trial
Hidetoshi Hayashi, Yuichi Takiguchi, Hironobu Minami, et al.
Plos One
|
February 4, 2017
Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer
Tatsuaki Takeda, Hiromasa Yamamoto, Hirotaka Kanzaki, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
November 10, 2020
The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis
Kota Araki, Rie Kinoshita, Nahoko Tomonobu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 3, 2019
Rapid Acquisition of Alectinib Resistance in ALK-Positive Lung Cancer With High Tumor Mutation Burden
Go Makimoto, Kadoaki Ohashi, Shuta Tomida, et al.
Journal of Gastroenterology
|
November 14, 2023
Marked intestinal trans-differentiation by autoimmune gastritis along with ectopic pancreatic and pulmonary trans-differentiation
Chihiro Takeuchi, Junichi Sato, Nobutake Yamamichi, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 169) with videos related to
Sort By:
Page
of 17
Journal of Molecular Medicine (Berlin, Germany)
|
December 17, 2023
Correction to: Periostin secreted by cancer‑associated fibroblasts promotes cancer progression and drug resistance in non‑small cell lung cancer
Fumiaki Takatsu, Ken Suzawa, Shuta Tomida, et al.
Scientific Reports
|
December 24, 2016
Interaction of cytokeratin 19 head domain and HER2 in the cytoplasm leads to activation of HER2-Erk pathway
Tomoaki Ohtsuka, Masakiyo Sakaguchi, Hiromasa Yamamoto, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
October 13, 2023
Periostin secreted by cancer-associated fibroblasts promotes cancer progression and drug resistance in non-small cell lung cancer
Fumiaki Takatsu, Ken Suzawa, Shuta Tomida, et al.
Cancer Immunology Research
|
July 1, 2025
Close Spatial Interactions between Cancer Cells and Cancer-Associated Fibroblasts Suppress Antitumor Immunity
Yuto Naoi, Yumi Inukai, Tomoka Izumikawa, et al.
Oncology Research
|
September 20, 2017
β-1,3-Galactosyl-<i>O</i>-Glycosyl-Glycoprotein β-1,6-<i>N</i>-Acetylglucosaminyltransferase 3 Increases MCAM Stability, Which Enhances S100A8/A9-Mediated Cancer Motility
I Wayan Sumardika, Chen Youyi, Eisaku Kondo, et al.
JAMA Oncology
|
October 15, 2020
Site-Specific and Targeted Therapy Based on Molecular Profiling by Next-Generation Sequencing for Cancer of Unknown Primary Site: A Nonrandomized Phase 2 Clinical Trial
Hidetoshi Hayashi, Yuichi Takiguchi, Hironobu Minami, et al.
Plos One
|
February 4, 2017
Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer
Tatsuaki Takeda, Hiromasa Yamamoto, Hirotaka Kanzaki, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
November 10, 2020
The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis
Kota Araki, Rie Kinoshita, Nahoko Tomonobu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 3, 2019
Rapid Acquisition of Alectinib Resistance in ALK-Positive Lung Cancer With High Tumor Mutation Burden
Go Makimoto, Kadoaki Ohashi, Shuta Tomida, et al.
Journal of Gastroenterology
|
November 14, 2023
Marked intestinal trans-differentiation by autoimmune gastritis along with ectopic pancreatic and pulmonary trans-differentiation
Chihiro Takeuchi, Junichi Sato, Nobutake Yamamichi, et al.
Page
of 17